Ruth Mokgokong

14PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersInnate immunityPacific Peoples theory of change models for healthHaematologyPacific Peoples and disability
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 06, 2026
Evaluation of nirmatrelvir/ritonavir treatment for COVID-19 on health-related outcomes: a global economic value systematic literature review.

|Mar 20, 2026
Health-related quality of life in immunocompromised adults with mild-moderate COVID-19 treated with nirmatrelvir-ritonavir: results from the randomized, double-blinded EPIC-IC trial.

Ruth Mokgokong, Paul Cislo, Elena Tudone

|Oct 14, 2025
Symptom Alleviation/Resolution and Returns to Usual Health/Activities in Immunocompromised Adults with COVID-19 Treated with Nirmatrelvir-Ritonavir: Results from the EPIC-IC Trial.

Ruth Mokgokong, Paul Cislo, Elena Tudone

|Sep 25, 2025
Comparative safety and effectiveness of direct oral anticoagulants and warfarin in patients with venous thromboembolism in Finland, Norway and Sweden.

Waleed Ghanima, Hanna Pohjantähti, Dimitra Lambrelli

|Aug 20, 2025
Development and content validation of the Long COVID/ post-acute sequelae of COVID-19 (PASC) patient-reported outcome (PRO) instrument.

Dale Chandler, Benjamin Abramoff, Candace Bramson

|Aug 05, 2025
Comparative analysis of all-cause health care resource utilization and costs among patients with non-valvular atrial fibrillation and high risk of gastrointestinal bleeding in France: a nationwide cohort analysis.

Giancarlo Pesce, Gaelle Gusto, Nadia Quignot

Pageof 3

Frequent Collaborators

3 joint publications

Nadia Quignot

2 joint publications

Laurent Bertoletti

2 joint publications

Jose Chaves

2 joint publications

Gregory Y H Lip